VeriChip Corporation (NASDAQ:CHIP), announced today that its wholly owned subsidiary, Xmark Corporation, has entered into a Teaming Agreement with Ekahau, a leading provider of Wi-Fi-based Real Time Location Systems (RTLS). Under the agreement, the two companies have agreed to collaborate on wireless solutions in the healthcare market to best meet customers' needs.

The agreement covers Xmark's RFID-based healthcare security systems and Ekahau's Wi-Fi-enabled RTLS. Specifically, the companies will collaborate on providing solutions around asset tracking, infant protection, patient safety and theft prevention in the healthcare industry. Solutions such as wander prevention, perimeter security and campus to bed-level tracking of assets are initial areas of focus for the collaboration. The two companies are also cooperating on an integrated solution that combines RFID and Wi-Fi technologies to suit the particular needs of certain customers.

Daniel A. Gunther, President and CEO of Xmark, said of the agreement, ?We expect this agreement to boost the market visibility of Xmark's Assetrac® asset tracking system, and further support sales of our infant protection and wander prevention systems. By partnering with Ekahau, we can offer our customers a broader range of solutions for all their locating, tracking and security needs.?

This agreement combines the best wireless solutions available to the healthcare marketplace,? said Antti Korhonen, president and CEO of Ekahau. ?Xmark offers a superior solution for a variety of security applications, while Ekahau has been extremely effective in tracking assets across large hospital campuses. Together we can offer hospitals the technology they need to meet their most urgent needs.?

IDTechEx, a UK-based consulting firm, has forecast that by 2016 the market for RFID tags and systems in the healthcare industry will grow to approximately $2.1 billion.

For more information on Xmark's products, please contact 1-866-55?XMARK or e-mail sales@xmark.com. Additional information can be found online at www.xmark.com. Information about Ekahau's RTLS product portfolio can be found online at www.ekahau.com, by calling 1-866-4EKAHAU, or e-mailing sales-americas@ekahau.com.

About Ekahau Inc.

Ekahau Inc. is the industry leader in providing Wi-Fi based RTLS solutions. Ekahau's customers, including several Fortune 500 companies worldwide, are realizing the benefits of Wi-Fi based location services and innovative Wi-Fi network planning and optimization tools. Ekahau partners include wireless software developers, leading system integrators, and international OEM partners, who develop and market wireless enterprise applications. Ekahau is a U.S. based corporation, with offices in Saratoga, CA; Reston, VA; Helsinki, Finland; and Hong Kong, China. For more information about Ekahau, please visit at www.ekahau.com.

About Xmark

Based in Ottawa, Ontario, Xmark is a wholly owned subsidiary of VeriChip Corporation. For over 25 years, Xmark Corporation has provided Radio Frequency Identification (RFID) solutions to identify, locate, and protect people and assets in healthcare environments. Its market-leading infant protection, wander prevention, personal duress, and asset tracking applications are trusted by over 5,000 healthcare institutions worldwide to keep individuals safe.

Xmark products are installed and serviced through an international network of authorized dealers, backed by a dedicated technical services department at Xmark. All aspects of Xmark's business are certified to the ISO 9001 quality standard. Additional information can be found online at www.xmark.com.

About VeriChip

VeriChip Corporation, headquartered in Delray Beach, Florida, develops, markets and sells radio frequency identification, or RFID, systems used to identify, locate and protect people and assets. VeriChip's goal is to become the leading provider of RFID systems for people in the healthcare industry. VeriChip recently began marketing its VeriMed(TM) Patient Identification System, a passive RFID system for rapidly and accurately identifying people who arrive in an emergency room and are unable to communicate. This system uses the first human-implantable passive RFID microchip, the implantable VeriChip(TM), cleared for medical use in October 2004 by the United States Food and Drug Administration.

VeriChip Corporation is majority-owned by Applied Digital Solutions Inc. (NASDAQ:ADSX), which also owns a majority position in Digital Angel Corporation (AMEX:DOC). For more information on VeriChip, please call 1-800-970-2447, or email info@verichipcorp.com. Additional information can be found online at http://www.verichipcorp.com.

Statements about the Company's future expectations, including future revenues and earnings, and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and the Company's actual results could differ materially from expected results. The Company undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances.

VeriChip Corporation, Delray Beach
Allison Tomek, 561-805-8008
atomek@adsx.com
or
CEOcast
Dan Schustack, 212-732-4300
or
Ekahau Media Contact:
Rocket Science PR
Juliet Travis, 415-464-8110 x 5
juliet@rocketscience.com